Stay updated on Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.
Latest updates to the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe website has added new features for user interaction while removing detailed options for participant groups, interventions, and various data fields related to studies.SummaryDifference3%
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference3%
- Check32 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.1%
- Check61 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
- Check68 days agoChange DetectedNew information has been added regarding KEYNOTE-033 and a Plain Language Summary, while previous notices about delays and an earlier version of the study record have been removed.SummaryDifference2%
Stay in the know with updates to Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.